INVENTIVA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-28
INVENTIVA
Equibles does not estimate personal net worth.
Jason Campagna has spoken on 1 earnings call across 1 company, most recently for INVENTIVA on September 28, 2026. INVENTIVA is classified in the Biotechnology industry within the Healthcare sector.
“I'll spend a few minutes on four aspects of our Lanifibinor development program in MASH. One, how Lanifibinor is designed to address the spectrum of disease. Two, what we've observed in the positive native Phase 2b clinical trial.”
INVENTIVA
Transcript header (unverified)
INVENTIVA
Biotechnology · Healthcare
Inventiva H1 2026 financial report
INVENTIVA